Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation.

ABSTRACT:

Background

Transcatheter aortic valve replacement (TAVR) in non-calcified aortic regurgitation (NCAR) is an off-label procedure. The balloon-expandable Myval includes extra-large sizes (30.5 mm and 32 mm) of interest in this setting.

Aims

We aimed to evaluate the safety and feasibility of Myval in NCAR.

Methods

This was an international, multicentre, observational study that enrolled all consecutive patients with symptomatic severe NCAR undergoing TAVR with the Myval device. The images were centrally analysed.

Results

A total of 113 patients were recruited, 64.6% were men, the mean age was 78.4±7.5 years, and the Society of Thoracic Surgeons score was 2.7±1.7%. Aortic root dilatation was present in 59.3% of patients, 7.1% were bicuspid, and the mean annular are

SUBMITTER: Sanchez-Luna JP 

PROVIDER: S-EPMC10500190 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature